Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Advisory - Health Canada warns about hand sanitizers that may pose health risks


OTTAWA, ON, Sept. 9, 2022 /CNW Telbec/ - Health Canada is advising that the following hand sanitizers are being recalled because they may pose health risks. For more information, including what you should do, visit the online safety alert.

Health Canada maintains this list of hand sanitizers that may pose health risks, so that consumers can easily identify products they may have purchased and take appropriate action. Consumers are encouraged to check it regularly for updates.

Product

Health Risk

Company

NPN or
DIN

Lot
Number

Expiry
Date

Action Taken

Zero Tolerance
Plus Sanitizer

Contains undeclared
impurity, benzene,
at elevated levels

Beauty In
Bulk

80098829

23-01-11

23-02-04

23-02-09

23-02-16

23-03-04

23-03-09

23-06-07

23-07-30

Jan 2023

Feb 2023

Feb 2023

Feb 2023

Mar 2023

Mar 2023

June 2023

July 2023

Product recalled by
company

Product licence suspended
by Health Canada

 

Stay connected with Health Canada and receive the latest advisories and product recalls.

SOURCE Health Canada


These press releases may also interest you

at 03:20
Launch of Phase 3 clinical trial with Nefecon in Japan
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
India-Based Dhiti Omics is Now Live on SOPHiA DDMtm
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI: Appointment of Adviser
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
If You Purchased, Paid, or Provided Reimbursement for Some or All of the Price of Branded Lipitor® or its Generic Equivalent, Atorvastatin Calcium, You Could Get Money From a Settlement
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

More news about Health...


News published on and distributed by: